Lung cancer symptoms in women
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Lung Cancer Symptoms in Women
Prevalence and Distress of Symptoms
Lung cancer is a leading cause of cancer-related deaths among women in the United States. Women with lung cancer often experience a range of distressing symptoms. The most prevalent and distressing symptoms include fatigue, frequent pain, and insomnia. Other common issues are poor outlook, dyspnea (difficulty breathing), and appetite disruptions. These symptoms significantly impact the quality of life and functional status of women with lung cancer.
Impact on Quality of Life
The quality of life (QOL) in women with lung cancer is notably disrupted. Women report significant difficulties with household chores, worry about their ability to care for themselves, and anxiety about cancer progression. Symptom distress is strongly associated with physical aspects of QOL and moderately with other dimensions of QOL. Women younger than 65 years, those with recurrent disease, and those with low income experience greater disruptions in their quality of life.
Gender Differences in Symptom Experience
While both men and women with inoperable lung cancer report many intense symptoms, women tend to report more severe emotional distress close to diagnosis. Over time, both genders show improvements in emotional functioning and some symptoms like dyspnea and insomnia, but physical functioning and fatigue often worsen. The differences in symptom experiences are influenced by factors such as age, education, civil status, and type of lung cancer.
Clinical Characteristics and Common Symptoms
The main symptoms prompting women to seek treatment for lung cancer include cough, hemoptysis (coughing up blood), chest pain, and dyspnea. Most women diagnosed with lung cancer are between 40 to 69 years old, with adenocarcinoma being the most common type, followed by small-cell lung cancer. Pleural effusion is also frequently observed in these patients.
Genetic Factors and Symptom Severity
Genetic variations, particularly in inflammation-related genes like interleukin-8 (IL-8) and interleukin-10 (IL-10), are associated with the severity of symptoms such as pain, depressed mood, and fatigue in lung cancer patients. These genetic factors, along with non-genetic factors, contribute to the occurrence and intensity of multiple symptoms.
Menstrual and Reproductive Factors
Menstrual and reproductive factors may influence lung cancer risk in women. Peri/postmenopausal women are at a higher risk compared to premenopausal women. Factors such as parity (number of children) and breastfeeding also play a role, with premenopausal women showing increased risks associated with higher parity and decreased risks with breastfeeding. However, smoking remains the most significant modifiable risk factor for lung cancer.
Conclusion
Women with lung cancer experience a range of distressing symptoms that significantly impact their quality of life. Factors such as age, recurrence of the disease, and income level further exacerbate these disruptions. Understanding the unique symptom experiences and genetic factors in women can help tailor more effective management and treatment strategies to improve their quality of life.
Sources and full results
Most relevant research papers on this topic